Skip to main navigation Skip to search Skip to main content

Remission of malabsorption in congenital intestinal lymphangiictasia following chemotherapy for lymphoma

  • Sheba Medical Center at Tel Hashomer
  • Tel Aviv University

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

A 22-year-old female with protein losing enteropathy due to congenital intestinal lymphangiectasia who developed non-Hodgkin's lymphoma of the bone, is described. Complete remission of the lymphomatous process and disappearance of the gastrointestinal symptoms were achieved following treatment with combination chemotherapy and local irradiation.

Original languageEnglish
Pages (from-to)147-148
Number of pages2
JournalLeukemia and Lymphoma
Volume11
Issue number1-2
DOIs
StatePublished - 1993
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bone lymphoma
  • Congenital intestinal
  • Lymphangiectasia

Fingerprint

Dive into the research topics of 'Remission of malabsorption in congenital intestinal lymphangiictasia following chemotherapy for lymphoma'. Together they form a unique fingerprint.

Cite this